Systematic review of disease-modifying antirheumatic drugs for juvenile idiopathic arthritis
<p>Abstract</p> <p>Background</p> <p>Treatment of juvenile idiopathic arthritis (JIA) with disease-modifying antirheumatic drugs (DMARDs) may improve outcomes compared to conventional therapy (e.g., non-steroidal anti-inflammatory drugs, intra-articular corticosteroids)...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-03-01
|
Series: | BMC Pediatrics |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2431/12/29 |